Dr. Theodora Suzanne Ross M.D.
Oncologist | Medical Oncology
1500 East Medical Center Dr B1 Floor Cancer & Ge Ann Arbor MI, 48109About
Dr. Theodora Ross is an oncologist practicing in Ann Arbor, MI. Dr. Ross specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Ross manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival.
- Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells.
- HIP1 and HIP1r stabilize receptor tyrosine kinases and bind 3-phosphoinositides via epsin N-terminal homology domains.
- Huntingtin Interacting Protein 1 mutations lead to abnormal hematopoiesis, spinal defects and cataracts.
- HIP1: trafficking roles and regulation of tumorigenesis.
- Hip1-related mutant mice grow and develop normally but have accelerated spinal abnormalities and dwarfism in the absence of HIP1.
- Serum antibodies to huntingtin interacting protein-1: a new blood test for prostate cancer.
- Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor.
- Degenerative phenotypes caused by the combined deficiency of murine HIP1 and HIP1r are rescued by human HIP1.
- Aberrant Huntingtin interacting protein 1 in lymphoid malignancies.
- Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues.
- Hip1r is expressed in gastric parietal cells and is required for tubulovesicle formation and cell survival in mice.
- Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder.
- Huntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit.
- Grace Rock's consent.
Dr. Theodora Suzanne Ross M.D.'s Practice location
Dr. Theodora Suzanne Ross M.D.'s reviews
Write ReviewRecommended Articles
- “Cancer Anger” - An Explanation
Following a cancer diagnosis, it is normal to be overwhelmed with a lot of different emotions. Some individuals may feel shocked and frightened, while others may feel sad, guilty, or upset. There is no right way to feel. ...
- What Is Cachexia?
Cachexia is a wasting syndrome, which is a process that causes fat tissues and muscle to waste away. This disorder causes involuntary weight loss, which often affects people with late-stage chronic diseases, such as cancer, renal disease, HIV or AIDS, and congestive heart failure.People with...
- What Is the Life Expectancy for Bladder Cancer?
What is a bladder?The bladder can be described as a hollow organ, which is located next to the kidneys. The bladder functions by collecting all the urine coming from the kidneys through the ureter. It then stores the urine until it is removed from the body.Having a bladder cancer causes an...
- Is Lower Back Pain a Sign of Testicular Cancer?
Testicular cancer affects the male sex organs called the testes, two oval shaped gonads located just beneath the penis, which are primarily responsible for producing male sex cells called sperm, as well as the male sex hormone called testosterone. Cancer mainly affects the germ cells, which in...
- The Link Between Breast Implants and Lymphoma
Throughout the years, implants have risen in popularity. On an annual basis, about 400,000 women in the United States get breast implants – around 300,000 for cosmetic enlargement and around 100,000 for breast reconstruction after cancer. In the year 2015, it was estimated that 1.4 million women...
- Is There Ever Enough Ovarian Cancer Research?
Recently, there has been much progress made in research of gynecological cancers. Many report that this period has been exceptionally productive in the field. However, despite how positive this is, many with gynecological cancers are upset that clinical trials are becoming decreasingly available, as...
Nearby Providers
- Dr. Massimo Arcerito MD1500 E Medical Center Dr Ann Arbor MI 48109
- Dr. Clara Hwang M.D.34815 W. Michigan Ave Wayne MI 48184
- M. Samm Pryce2190 South State Street Ann Arbor Michigan 48104
- Dr. Oleg Krijanovski MD, PHD1500 East Medical Center Dr Ann Arbor MI 48109
- Dr. Ulka Nitin Vaishampayan MD1500 E MEDICAL CENTER DR ANN ARBOR MI 48109
- Dr. Mark M Zalupski MD1500 East Medical Center Dr Ann Arbor MI 48109